| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | SAGA complex | 4.70e-05 | 25 | 59 | 3 | GO:0000124 | |
| GeneOntologyCellularComponent | SAGA-type complex | 1.82e-04 | 39 | 59 | 3 | GO:0070461 | |
| Domain | Cornifin | 4.90e-05 | 4 | 54 | 2 | IPR003302 | |
| Domain | SPRR/LCE | 7.11e-05 | 28 | 54 | 3 | IPR026075 | |
| Domain | DUF4599 | 5.32e-04 | 12 | 54 | 2 | PF15371 | |
| Domain | DUF4599 | 5.32e-04 | 12 | 54 | 2 | IPR027970 | |
| Domain | C2 | 5.57e-04 | 131 | 54 | 4 | PF00168 | |
| Domain | C2 | 6.59e-04 | 137 | 54 | 4 | SM00239 | |
| Domain | Pept_M10A_Zn_BS | 8.41e-04 | 15 | 54 | 2 | IPR021158 | |
| Domain | - | 8.80e-04 | 148 | 54 | 4 | 2.60.40.150 | |
| Domain | Hemopexin_CS | 1.09e-03 | 17 | 54 | 2 | IPR018486 | |
| Domain | Pept_M10A_stromelysin-type | 1.22e-03 | 18 | 54 | 2 | IPR016293 | |
| Domain | C2_dom | 1.29e-03 | 164 | 54 | 4 | IPR000008 | |
| Domain | Synaptotagmin | 1.51e-03 | 20 | 54 | 2 | IPR001565 | |
| Domain | PG_binding_1 | 1.51e-03 | 20 | 54 | 2 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 1.51e-03 | 20 | 54 | 2 | IPR002477 | |
| Domain | Hemopexin-like_dom | 2.00e-03 | 23 | 54 | 2 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 2.00e-03 | 23 | 54 | 2 | IPR018487 | |
| Domain | M10A_MMP | 2.00e-03 | 23 | 54 | 2 | IPR033739 | |
| Domain | Hemopexin | 2.00e-03 | 23 | 54 | 2 | PF00045 | |
| Domain | HEMOPEXIN | 2.00e-03 | 23 | 54 | 2 | PS00024 | |
| Domain | - | 2.00e-03 | 23 | 54 | 2 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 2.00e-03 | 23 | 54 | 2 | PS51642 | |
| Domain | HX | 2.00e-03 | 23 | 54 | 2 | SM00120 | |
| Domain | Pept_M10A | 2.00e-03 | 23 | 54 | 2 | IPR021190 | |
| Domain | Peptidase_M10 | 2.17e-03 | 24 | 54 | 2 | PF00413 | |
| Domain | ZnMc | 3.17e-03 | 29 | 54 | 2 | SM00235 | |
| Domain | Peptidase_Metallo | 3.17e-03 | 29 | 54 | 2 | IPR006026 | |
| Domain | CYSTEINE_SWITCH | 6.26e-03 | 41 | 54 | 2 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 6.87e-03 | 43 | 54 | 2 | IPR001818 | |
| Domain | C2 | 8.04e-03 | 142 | 54 | 3 | PS50004 | |
| Pubmed | 1.01e-06 | 12 | 59 | 3 | 9888996 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 8018055 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 29532899 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 34571507 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 30328228 | ||
| Pubmed | Salt-inducible kinase 3 regulates the mammalian circadian clock by destabilizing PER2 protein. | 2.83e-06 | 2 | 59 | 2 | 29227248 | |
| Pubmed | Prevotella intermedia upregulates MMP-1 and MMP-8 expression in human periodontal ligament cells. | 2.83e-06 | 2 | 59 | 2 | 19708869 | |
| Pubmed | Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. | 2.83e-06 | 2 | 59 | 2 | 15718477 | |
| Pubmed | ZNF462 GPR158 KSR2 SIK3 CDC42BPB AGRN RPH3A RAB3C GOLGA3 LDB2 | 4.65e-06 | 963 | 59 | 10 | 28671696 | |
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | 8.02e-06 | 23 | 59 | 3 | 11698679 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 33902302 | ||
| Pubmed | Transglutaminase 5 cross-links loricrin, involucrin, and small proline-rich proteins in vitro. | 8.48e-06 | 3 | 59 | 2 | 11443109 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 26132583 | ||
| Pubmed | Polymorphism +17 C/G in matrix metalloprotease MMP8 decreases lung cancer risk. | 8.48e-06 | 3 | 59 | 2 | 19094243 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 7829876 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 18366705 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 27313452 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 24220028 | ||
| Pubmed | Collagenase expression and activity in the stromal cells from giant cell tumour of bone. | 8.48e-06 | 3 | 59 | 2 | 19442604 | |
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 29215835 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 30626536 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 29453088 | ||
| Pubmed | 1.47e-05 | 28 | 59 | 3 | 19114550 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 19995403 | ||
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 29263043 | ||
| Pubmed | [The system of matrix metalloproteinases and their role in patients with pulmonary tuberculosis]. | 1.69e-05 | 4 | 59 | 2 | 27797337 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 21432777 | ||
| Pubmed | 1.82e-05 | 30 | 59 | 3 | 18206972 | ||
| Pubmed | 2.02e-05 | 31 | 59 | 3 | 20930145 | ||
| Pubmed | 2.27e-05 | 199 | 59 | 5 | 23382691 | ||
| Pubmed | 2.44e-05 | 33 | 59 | 3 | 11564863 | ||
| Pubmed | Membrane-type 1 MMP (MMP-14) cleaves at three sites in the aggrecan interglobular domain. | 2.82e-05 | 5 | 59 | 2 | 9688535 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 9115270 | ||
| Pubmed | Matrix metalloproteinases: structures, evolution, and diversification. | 2.82e-05 | 5 | 59 | 2 | 9737711 | |
| Pubmed | 4.08e-05 | 225 | 59 | 5 | 12168954 | ||
| Pubmed | Piccolo, a presynaptic zinc finger protein structurally related to bassoon. | 4.23e-05 | 6 | 59 | 2 | 10707984 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 27304082 | ||
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 10441742 | ||
| Pubmed | Matrix metalloproteinase polymorphisms and bladder cancer risk. | 4.23e-05 | 6 | 59 | 2 | 17178858 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 7998967 | ||
| Pubmed | Matrix metalloproteinase polymorphisms are associated with bladder cancer invasiveness. | 4.23e-05 | 6 | 59 | 2 | 17473191 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 12054629 | ||
| Pubmed | Fine physical mapping of the human matrix metalloproteinase genes clustered on chromosome 11q22.3. | 5.91e-05 | 7 | 59 | 2 | 8921407 | |
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 17307908 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 11359932 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 8216228 | ||
| Pubmed | Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP). | 5.91e-05 | 7 | 59 | 2 | 10922468 | |
| Pubmed | Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. | 5.91e-05 | 7 | 59 | 2 | 10859319 | |
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 11113146 | ||
| Pubmed | Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function. | 5.91e-05 | 7 | 59 | 2 | 33542309 | |
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 25770908 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 10908733 | ||
| Pubmed | Characterization of opticin digestion by proteases involved in osteoarthritis development. | 7.87e-05 | 8 | 59 | 2 | 23845380 | |
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 21802298 | ||
| Pubmed | Effect of combined genetic polymorphisms on lung cancer risk in northern Thai women. | 7.87e-05 | 8 | 59 | 2 | 19963114 | |
| Pubmed | A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis. | 7.87e-05 | 8 | 59 | 2 | 27579896 | |
| Pubmed | Mouse Sprr locus: a tandem array of coordinately regulated genes. | 7.87e-05 | 8 | 59 | 2 | 12584609 | |
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 15574822 | ||
| Pubmed | 1.01e-04 | 9 | 59 | 2 | 11279051 | ||
| Pubmed | Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. | 1.01e-04 | 9 | 59 | 2 | 10986281 | |
| Pubmed | 1.26e-04 | 10 | 59 | 2 | 8325635 | ||
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 1.54e-04 | 11 | 59 | 2 | 17023412 | |
| Pubmed | Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects. | 1.54e-04 | 11 | 59 | 2 | 24051374 | |
| Pubmed | 1.73e-04 | 163 | 59 | 4 | 24316575 | ||
| Pubmed | 1.85e-04 | 12 | 59 | 2 | 12149192 | ||
| Pubmed | 1.85e-04 | 12 | 59 | 2 | 18643845 | ||
| Pubmed | Fate and plasticity of the epidermis in response to congenital activation of BRAF. | 2.18e-04 | 13 | 59 | 2 | 25202828 | |
| Pubmed | 2.18e-04 | 13 | 59 | 2 | 8999895 | ||
| Pubmed | 2.18e-04 | 13 | 59 | 2 | 21485009 | ||
| Pubmed | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. | 2.54e-04 | 14 | 59 | 2 | 28263302 | |
| Pubmed | 2.54e-04 | 14 | 59 | 2 | 16236725 | ||
| Pubmed | WNT signals are required for the initiation of hair follicle development. | 2.93e-04 | 15 | 59 | 2 | 12015971 | |
| Pubmed | 3.30e-04 | 193 | 59 | 4 | 22589738 | ||
| Pubmed | An approach based on a genome-wide association study reveals candidate loci for narcolepsy. | 3.30e-04 | 193 | 59 | 4 | 20677014 | |
| Pubmed | 3.34e-04 | 16 | 59 | 2 | 20484597 | ||
| Pubmed | 3.34e-04 | 16 | 59 | 2 | 21930775 | ||
| Pubmed | 3.34e-04 | 16 | 59 | 2 | 37701782 | ||
| Pubmed | beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. | 3.79e-04 | 17 | 59 | 2 | 11371349 | |
| Pubmed | LIM-homeodomain gene Lhx2 regulates the formation of the cortical hem. | 4.75e-04 | 19 | 59 | 2 | 11165475 | |
| Pubmed | 5.82e-04 | 21 | 59 | 2 | 24198274 | ||
| Pubmed | Bcl11b/Ctip2 is required for development of lingual papillae in mice. | 5.82e-04 | 21 | 59 | 2 | 27287879 | |
| Pubmed | Sox2 modulates the function of two distinct cell lineages in mouse skin. | 5.82e-04 | 21 | 59 | 2 | 23948231 | |
| Pubmed | Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients. | 5.82e-04 | 21 | 59 | 2 | 19601998 | |
| Pubmed | Cripto is required for mesoderm and endoderm cell allocation during mouse gastrulation. | 5.82e-04 | 21 | 59 | 2 | 23747598 | |
| Pubmed | 5.82e-04 | 21 | 59 | 2 | 27894818 | ||
| Pubmed | Functional interactions between matrix metalloproteinases and glycosaminoglycans. | 6.39e-04 | 22 | 59 | 2 | 23421805 | |
| Pubmed | 6.39e-04 | 22 | 59 | 2 | 16751104 | ||
| Pubmed | BMP signaling in the development of the mouse esophagus and forestomach. | 6.39e-04 | 22 | 59 | 2 | 21068065 | |
| Pubmed | 6.39e-04 | 22 | 59 | 2 | 10419448 | ||
| Pubmed | 7.00e-04 | 23 | 59 | 2 | 18602769 | ||
| Pubmed | Transcription Factor MafB Coordinates Epidermal Keratinocyte Differentiation. | 7.62e-04 | 24 | 59 | 2 | 27208706 | |
| Pubmed | 8.28e-04 | 25 | 59 | 2 | 23132931 | ||
| Pubmed | 8.28e-04 | 25 | 59 | 2 | 31410202 | ||
| Pubmed | Insulin/IGF-1 controls epidermal morphogenesis via regulation of FoxO-mediated p63 inhibition. | 8.28e-04 | 25 | 59 | 2 | 23906066 | |
| Pubmed | 8.28e-04 | 25 | 59 | 2 | 17684299 | ||
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 8.96e-04 | 26 | 59 | 2 | 17124501 | |
| Pubmed | Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation. | 8.96e-04 | 26 | 59 | 2 | 12805214 | |
| Pubmed | 1.00e-03 | 115 | 59 | 3 | 20485444 | ||
| Pubmed | Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling. | 1.05e-03 | 117 | 59 | 3 | 22682244 | |
| Pubmed | Global analysis of gene expression in the developing brain of Gtf2ird1 knockout mice. | 1.12e-03 | 29 | 59 | 2 | 21909369 | |
| Cytoband | 9q21.32 | 2.74e-04 | 19 | 59 | 2 | 9q21.32 | |
| Cytoband | Xp22.11 | 3.36e-04 | 21 | 59 | 2 | Xp22.11 | |
| Cytoband | 1q21-q22 | 4.04e-04 | 23 | 59 | 2 | 1q21-q22 | |
| Cytoband | 11q22.3 | 1.48e-03 | 44 | 59 | 2 | 11q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 1.84e-03 | 404 | 59 | 4 | chr1q21 | |
| GeneFamily | Small proline rich proteins | 1.98e-04 | 11 | 35 | 2 | 1353 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 9.78e-04 | 24 | 35 | 2 | 891 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.20e-03 | 36 | 35 | 2 | 823 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.35e-06 | 189 | 57 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.33e-05 | 130 | 57 | 4 | 05d5a73acf1d7f75a79876b1a06d27c74a89b8a4 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.48e-05 | 132 | 57 | 4 | 780a391924f776dc6fbe44ddcf4ae0583a1e2157 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.71e-05 | 135 | 57 | 4 | 366a417f9ef7c0d86e9f262d97bf788f478315ee | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|blood / Manually curated celltypes from each tissue | 2.79e-05 | 136 | 57 | 4 | f024015bf60e64b8657e410e24995a1edec85196 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.76e-05 | 156 | 57 | 4 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | facs-Lung-24m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.51e-05 | 162 | 57 | 4 | 4e418bea07e35038b32a78a1e6632b6ec1208cdc | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.50e-05 | 169 | 57 | 4 | 4a5d023ffcf83312d29b1d215eb6b744ef1a0777 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.50e-05 | 169 | 57 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-Developing_Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 6.65e-05 | 170 | 57 | 4 | cfd7f29805b7c51666b0eaf269c36c96b8765a1a | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.65e-05 | 170 | 57 | 4 | 13a225e32132e9717debb0d64d7c28ada974c3e6 | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 6.96e-05 | 172 | 57 | 4 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.96e-05 | 172 | 57 | 4 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 7.44e-05 | 175 | 57 | 4 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-05 | 178 | 57 | 4 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.29e-05 | 180 | 57 | 4 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Adora1_(Striatum,_interneuron)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.34e-05 | 66 | 57 | 3 | d6b202d9f5bebaac23b34b689ad306549dec0593 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Adora1_(Striatum,_interneuron)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.34e-05 | 66 | 57 | 3 | 4a714cf035b22da103054098f85f9170c56e9e83 | |
| ToppCell | PSB-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.84e-05 | 183 | 57 | 4 | 2cf798a2371c61322484ea16fdfae0acfa94f102 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.22e-05 | 185 | 57 | 4 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.22e-05 | 185 | 57 | 4 | f3fbc3096f85397a959cee17c3c4fcf2d511f3d5 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 186 | 57 | 4 | e52cf44989c57c433bf82e9fa13b4643e88f3577 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 186 | 57 | 4 | 4c0b59d845b79323e7a3287e7c4d249f5f322556 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.41e-05 | 186 | 57 | 4 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-SCG3+_lymphatic_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.00e-04 | 189 | 57 | 4 | f0418851ad4042c4cd87c8729e4f0d43bdf8fccb | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 190 | 57 | 4 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | BL-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.04e-04 | 191 | 57 | 4 | 3f9b8c4fb72ae6f3167b187e6715c4dcb3159f98 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 191 | 57 | 4 | fbd8d337b4444fba8527a614e4a8bfb516ce0f66 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 191 | 57 | 4 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_upper|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.06e-04 | 192 | 57 | 4 | 69b6b3ceaad6432c46d1bc2a00b8389069a8876e | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.06e-04 | 192 | 57 | 4 | 103496f428f59683ac3ae6147682c07c30663724 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.11e-04 | 194 | 57 | 4 | 53a34843d529ef395deb27086f71f7049a087bab | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.11e-04 | 194 | 57 | 4 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue | 1.13e-04 | 195 | 57 | 4 | 972b09697b7b66fb8a27dfc0c0b05a844121f055 | |
| ToppCell | NS-moderate-d_07-13|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.13e-04 | 195 | 57 | 4 | 088209505a68519ec89f50f0576096da6966bf17 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo|Liver / Manually curated celltypes from each tissue | 1.13e-04 | 195 | 57 | 4 | c29c4ae95a756e3ced0f0747bbfe343590e5b8ab | |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 195 | 57 | 4 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Squamous|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.15e-04 | 196 | 57 | 4 | 97e16d9833e4083d719ca7058d5fc9b11edb37e3 | |
| ToppCell | NS-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.15e-04 | 196 | 57 | 4 | 453c809494ceffa2a28af283c4b5a4924fcf160f | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.15e-04 | 196 | 57 | 4 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 197 | 57 | 4 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | critical-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.17e-04 | 197 | 57 | 4 | cfbdaada7169afb68455724ae87032ff311b2d89 | |
| ToppCell | NS-control-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.17e-04 | 197 | 57 | 4 | ab965a0ba87efd3329d24a1ec123985f46fc17c0 | |
| ToppCell | moderate-Epithelial-Squamous|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.17e-04 | 197 | 57 | 4 | ab3c90a5b643b45d0b83939c6304b11f567c5d78 | |
| ToppCell | critical-Epithelial-Squamous|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.17e-04 | 197 | 57 | 4 | eccc80d6ab79c46b10108de1cff3abeacfc105cd | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-04 | 197 | 57 | 4 | 861e8df9bd74dc5e17bafdc1fb3fef546753c73a | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.17e-04 | 197 | 57 | 4 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 1.17e-04 | 197 | 57 | 4 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 197 | 57 | 4 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | moderate-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.17e-04 | 197 | 57 | 4 | 2e13881f917d4f62a5b3e968e41c57e43300d988 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-04 | 197 | 57 | 4 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | control-Epithelial-Squamous|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.20e-04 | 198 | 57 | 4 | 6ba669ac1ed275ae309054941b1457e315766faa | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Squamous|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.20e-04 | 198 | 57 | 4 | b7495369baba203490c067a58fc8456a778a12e4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 198 | 57 | 4 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 198 | 57 | 4 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | control-Epithelial-Squamous|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.22e-04 | 199 | 57 | 4 | e13dca7a055cdca53dd6c26c04b2a46d58b419b6 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 1.22e-04 | 199 | 57 | 4 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | distal-1-Epithelial-Differentiating_Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-04 | 199 | 57 | 4 | fe7d6f70fe337b91b0ad63ea33e5a714d2df87bd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-04 | 200 | 57 | 4 | ac0e023dbb383bbc46c5cc525431778be8f7ef46 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-04 | 200 | 57 | 4 | e90155498397524b812c46f2412320230b445bb6 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tumor_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.24e-04 | 200 | 57 | 4 | 9c1b30fa96565515a7160f439cadcd51482c41e9 | |
| Drug | METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID | 5.32e-06 | 2 | 53 | 2 | DB08403 | |
| Drug | trimeprazine | 1.12e-05 | 19 | 53 | 3 | CID000005574 | |
| Drug | 5-mercapto-1,3,4-thiadiazole 13c | 1.59e-05 | 3 | 53 | 2 | CID010030894 | |
| Drug | Hydroxamate 44 | 1.59e-05 | 3 | 53 | 2 | CID010027203 | |
| Drug | Hydroxamate 39 | 1.59e-05 | 3 | 53 | 2 | CID011036991 | |
| Drug | (2S)-2-[(2-nitrobenzyl)-(1,1,2,2,3,3,4,4,4-nonafluorobutylsulfonyl)amino]propanehydroxamic acid | 1.59e-05 | 3 | 53 | 2 | CID010994933 | |
| Drug | Hydroxamate 36 | 1.59e-05 | 3 | 53 | 2 | CID010500886 | |
| Drug | 5-mercapto-1,3,4-thiadiazole 13b | 1.59e-05 | 3 | 53 | 2 | CID011757336 | |
| Drug | carbamoylphosphonic acid | 3.18e-05 | 4 | 53 | 2 | CID013879809 | |
| Drug | 3-hydroxypicolinic acid | 3.18e-05 | 4 | 53 | 2 | ctd:C049246 | |
| Drug | (2S)-2-[(2-nitrobenzyl)-(2,3,4,5,6-pentafluorophenyl)sulfonyl-amino]propanehydroxamic acid | 3.18e-05 | 4 | 53 | 2 | CID011037999 | |
| Drug | 1,2-DAA | 5.29e-05 | 5 | 53 | 2 | CID000015652 | |
| Drug | beta-sulfone 7f | 5.29e-05 | 5 | 53 | 2 | CID011526076 | |
| Drug | alpha-sulfone 27e | 5.29e-05 | 5 | 53 | 2 | CID011719408 | |
| Drug | MMP-3 inhibitor | 5.29e-05 | 5 | 53 | 2 | CID010549329 | |
| Drug | Hydroxamate 33 | 5.29e-05 | 5 | 53 | 2 | CID010810684 | |
| Drug | beta-sulfone 7e | 5.29e-05 | 5 | 53 | 2 | CID011641261 | |
| Drug | beta-sulfone 7b | 5.29e-05 | 5 | 53 | 2 | CID009867183 | |
| Drug | Hydroxamate 31 | 5.29e-05 | 5 | 53 | 2 | CID011799753 | |
| Drug | Hydroxysulfonamide 66 | 5.29e-05 | 5 | 53 | 2 | CID012635073 | |
| Drug | CTS-1027 | 5.29e-05 | 5 | 53 | 2 | CID003342298 | |
| Drug | CGS 25966 | 5.29e-05 | 5 | 53 | 2 | CID009821883 | |
| Drug | SC-276 | 5.29e-05 | 5 | 53 | 2 | CID009802768 | |
| Drug | alpha-sulfone 35g | 5.29e-05 | 5 | 53 | 2 | CID011705502 | |
| Drug | Hydroxamate 34 | 5.29e-05 | 5 | 53 | 2 | CID010529602 | |
| Drug | beta-sulfone 7d | 5.29e-05 | 5 | 53 | 2 | CID011548264 | |
| Drug | alpha-sulfone 27d | 5.29e-05 | 5 | 53 | 2 | CID011532911 | |
| Drug | alpha-sulfone 27g | 5.29e-05 | 5 | 53 | 2 | CID011561491 | |
| Drug | glucothiose | 5.29e-05 | 5 | 53 | 2 | CID000175998 | |
| Drug | I01-10485 | 5.29e-05 | 5 | 53 | 2 | CID011009332 | |
| Drug | alpha-sulfone 27b | 5.29e-05 | 5 | 53 | 2 | CID011697282 | |
| Drug | beta-sulfone 7c | 5.29e-05 | 5 | 53 | 2 | CID011613649 | |
| Drug | glutaraldehyde | 6.83e-05 | 94 | 53 | 4 | CID000003485 | |
| Drug | Hydroxamate 32 | 7.93e-05 | 6 | 53 | 2 | CID010671441 | |
| Drug | Hydroxamate 26 | 7.93e-05 | 6 | 53 | 2 | CID010833334 | |
| Drug | NSC47818 | 7.93e-05 | 6 | 53 | 2 | CID000240910 | |
| Drug | Hydroxysulfonamide 69 | 7.93e-05 | 6 | 53 | 2 | CID010610114 | |
| Drug | NSC-139458 | 7.93e-05 | 6 | 53 | 2 | CID000283995 | |
| Drug | Hydroxamate 35 | 7.93e-05 | 6 | 53 | 2 | CID010456675 | |
| Drug | 2-Amino-5-mercapto-1,3,4-thiadiazole | 7.93e-05 | 6 | 53 | 2 | CID002723847 | |
| Drug | Hydroxamate 28 | 7.93e-05 | 6 | 53 | 2 | CID010792025 | |
| Drug | Hydroxamate 12 | 7.93e-05 | 6 | 53 | 2 | CID010594000 | |
| Drug | (2S)-2-[benzyl-(2,3,4,5,6-pentafluorophenyl)sulfonylamino]-N-hydroxy-3-methylbutanamide | 7.93e-05 | 6 | 53 | 2 | CID010694926 | |
| Drug | Hydroxamate 10 | 7.93e-05 | 6 | 53 | 2 | CID010837740 | |
| Drug | Hydroxamate 29 | 7.93e-05 | 6 | 53 | 2 | CID010766622 | |
| Drug | Hydroxamate 8 | 7.93e-05 | 6 | 53 | 2 | CID010758013 | |
| Drug | Hydroxamate 14 | 7.93e-05 | 6 | 53 | 2 | CID010042482 | |
| Drug | sulfoxamine | 7.93e-05 | 6 | 53 | 2 | CID003000415 | |
| Drug | (2S)-2-[benzyl(1,1,2,2,3,3,4,4,4-nonafluorobutylsulfonyl)amino]-N-hydroxy-3-methylbutanamide | 7.93e-05 | 6 | 53 | 2 | CID010696860 | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.96e-05 | 190 | 53 | 5 | 3966_DN | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; PC3; HT_HG-U133A | 9.00e-05 | 195 | 53 | 5 | 3802_DN | |
| Drug | hydroxamate 20 | 1.11e-04 | 7 | 53 | 2 | CID011792968 | |
| Drug | CGS 27023A Analog 51 | 1.11e-04 | 7 | 53 | 2 | CID010594938 | |
| Drug | Ro 32-3555 | 1.48e-04 | 8 | 53 | 2 | CID000193987 | |
| Drug | Sc 40827 | 1.48e-04 | 8 | 53 | 2 | CID000127918 | |
| Drug | hydroxamate 11 | 1.48e-04 | 8 | 53 | 2 | CID010001582 | |
| Drug | Marimastat | 1.48e-04 | 8 | 53 | 2 | DB00786 | |
| Drug | (1R,2R,4S,5R)-6-methylolcyclohexane-1,2,3,4,5-pentol | 1.89e-04 | 9 | 53 | 2 | CID011321479 | |
| Drug | CGS 27023A | 1.89e-04 | 9 | 53 | 2 | ctd:C097658 | |
| Drug | delta-(l-alpha-aminoadipoyl)-l-cysteinyl-glycine | 1.91e-04 | 229 | 53 | 5 | CID004369448 | |
| Drug | C11536 | 2.29e-04 | 51 | 53 | 3 | CID000443249 | |
| Drug | desmosine | 2.57e-04 | 53 | 53 | 3 | CID000025435 | |
| Drug | benzoyl isothiocyanate | 2.89e-04 | 11 | 53 | 2 | CID000068284 | |
| Drug | eckol | 2.89e-04 | 11 | 53 | 2 | CID000145937 | |
| Drug | pirfenidone | 3.00e-04 | 138 | 53 | 4 | CID000040632 | |
| Drug | meloxicam | 3.03e-04 | 56 | 53 | 3 | CID000004051 | |
| Drug | AC1L1H8O | 3.71e-04 | 60 | 53 | 3 | CID000005106 | |
| Disease | Major Depressive Disorder | 8.27e-05 | 243 | 54 | 5 | C1269683 | |
| Disease | Abnormality of refraction | 2.17e-04 | 673 | 54 | 7 | HP_0000539 | |
| Disease | thoracic aortic aneurysm (is_marker_for) | 2.95e-04 | 14 | 54 | 2 | DOID:14004 (is_marker_for) | |
| Disease | Pontoneocerebellar hypoplasia | 3.88e-04 | 16 | 54 | 2 | cv:C1261175 | |
| Disease | visceral adipose tissue measurement, body mass index | 5.51e-04 | 87 | 54 | 3 | EFO_0004340, EFO_0004765 | |
| Disease | carotid artery disease (is_implicated_in) | 7.42e-04 | 22 | 54 | 2 | DOID:3407 (is_implicated_in) | |
| Disease | waist circumference | 1.12e-03 | 429 | 54 | 5 | EFO_0004342 | |
| Disease | chronic obstructive pulmonary disease (biomarker_via_orthology) | 1.21e-03 | 28 | 54 | 2 | DOID:3083 (biomarker_via_orthology) | |
| Disease | Unipolar Depression | 1.30e-03 | 259 | 54 | 4 | C0041696 | |
| Disease | Alcoholic Intoxication | 1.57e-03 | 32 | 54 | 2 | C0001969 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QTPNPPKEVEPSPVQ | 91 | Q6ZRG5 | |
| VTIEPPNPINPSTNC | 401 | Q8IVW4 | |
| PQQPPKPCDSQPCFH | 1326 | O00468 | |
| SQPPQPVVPAKPVQC | 31 | Q9NR22 | |
| ESTKPGPVCQPPVSQ | 201 | Q6AI12 | |
| INPETVPKPCCAPTQ | 386 | P18075 | |
| NPIQPTGPSTPKPCD | 266 | P22894 | |
| QEICPNEDFCPPPPN | 596 | P24386 | |
| NTRLKETPPPPQPNC | 211 | Q96E17 | |
| TKGPAPAPQQCSEPE | 481 | Q3YEC7 | |
| EEAQPQSPAPDPPCS | 371 | Q96NA2 | |
| SKDVPPCQEPPPAQD | 761 | P49796 | |
| PCQEPPPAQDLSPCQ | 766 | P49796 | |
| PQAQDKRPAVTPQPC | 256 | A8MXZ1 | |
| PAPQNSNPAEEPRKP | 956 | Q5T848 | |
| CPSQPPVFPAAKQCP | 51 | O95998 | |
| PTTETGKENNPVCPP | 171 | Q6VAB6 | |
| PPATQETKSENPPPQ | 356 | O43679 | |
| PQAQDKRPAVTPQPC | 256 | A8MWA6 | |
| PPSPNIQCDDPQPVA | 886 | P38570 | |
| PSNPTKEPVEPQPSQ | 11 | O15055 | |
| PQPPCTAKPDQVEPG | 1321 | Q9Y6V0 | |
| PPVMPDECPQAQPTN | 81 | O43157 | |
| VQQPPCFPLKIPPND | 286 | P05164 | |
| KDPCPQVAQPIPQPQ | 296 | Q8WXX7 | |
| KSEQLPPCVNPGNPV | 21 | H3BRN8 | |
| APQVCPIPPEQSKRP | 1071 | Q9Y5S2 | |
| PGPLVPPDQQDKVQC | 31 | Q08378 | |
| PPENQNPASPDVVPC | 266 | Q9H5V7 | |
| NPASPDVVPCPDEKP | 271 | Q9H5V7 | |
| TPKPCQDPPANFPLT | 321 | Q3B8N5 | |
| PSSQPDSQEKPAQPP | 366 | Q711Q0 | |
| QQKPSSLPPAPCPSE | 626 | Q8N960 | |
| PESPEVTQNPPTQPK | 2146 | Q8N3K9 | |
| PPTCKVQEQPPAIPE | 31 | Q9Y2A9 | |
| CPPKNPVQCLPPASS | 21 | Q5T5B0 | |
| QAPPPKSPPVVIQCQ | 2891 | Q6ZTR5 | |
| EILPSTPNPQPPSCQ | 316 | Q16690 | |
| PQAQDKRPAVTPQPC | 256 | P0C7X0 | |
| LPNPPPESAPAQCKV | 1056 | A6NGG8 | |
| EDCLNPPSEPRQPNP | 781 | Q9UN75 | |
| CQPAIPENPPPAPKE | 141 | P49848 | |
| KPQQPVSEPAAPEQP | 176 | Q9Y2J0 | |
| SVKPQQEQSDCPPPP | 246 | Q3ZLR7 | |
| PPPCSQPSQCPEEKP | 231 | Q7Z6J9 | |
| QPSQCPEEKPQESSP | 236 | Q7Z6J9 | |
| EQSQSQPCPQPSCPP | 4201 | A2VEC9 | |
| PVQPIGPQTPKACDS | 266 | P03956 | |
| PFFPEDPQQSNPCPE | 191 | O95255 | |
| EPVQAQPPQPCSSPS | 301 | O94761 | |
| DSVPLPPCQEQQPKA | 571 | Q8IXR5 | |
| PQTPEPLPKACSNPS | 306 | Q86YN6 | |
| CPPLPCQQEALQPEP | 361 | P31391 | |
| PQPSPPLQAACENQP | 701 | Q9Y2K2 | |
| TPKESPNPPNPSGQC | 56 | Q9NVS2 | |
| PEVHEPPQEKQEPPC | 291 | Q96M53 | |
| PPQEKQEPPCSQSPK | 296 | Q96M53 | |
| QKSQEDFCPPAPNPV | 641 | Q6ZUB0 | |
| QPTPLPPPCQKVPVE | 36 | P07476 | |
| PAEVPQEPQEPTQTP | 46 | A0A1W2PS18 | |
| EPCPSTVTPGPAQQK | 151 | Q9UBC9 | |
| SVKPQQEQSDCPPPP | 246 | P0C7V6 | |
| QKSQEDFCPPAPNPV | 641 | P0C874 | |
| PPPPCKIENSIPNPN | 1691 | Q13129 | |
| QPKVPEPCPSTVTPA | 66 | P35321 | |
| PVNCENSIPTPFPEQ | 1426 | Q96JM2 |